Skip to main content

ADMA Biologics, Inc. (ADMA)

NASDAQ: ADMA · IEX Real-Time Price · USD
4.52
0.00 (0.00%)
At close: Dec 29, 2023, 4:00 PM
4.53
+0.01 (0.24%)
After-hours: Dec 29, 2023, 7:17 PM EST

ADMA Biologics Revenue

ADMA Biologics had revenue of $234.29M in the twelve months ending September 30, 2023, with 79.56% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $67.27M with 63.72% year-over-year growth. In the year 2022, ADMA Biologics had annual revenue of $154.08M with 90.36% growth.

Revenue (ttm)
$234.29M
Revenue Growth
+79.56%
P/S Ratio
4.36
Revenue / Employee
$379,729
Employees
617
Market Cap
1.02B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2022154.08M73.14M
90.36%
Dec 31, 202180.94M38.72M
91.72%
Dec 31, 202042.22M12.87M
43.85%
Dec 31, 201929.35M12.36M
72.79%
Dec 31, 201816.99M-5.78M
-25.37%
Dec 31, 201722.76M12.10M
113.49%
Dec 31, 201610.66M3.48M
48.53%
Dec 31, 20157.18M1.26M
21.34%
Dec 31, 20145.92M2.85M
92.84%
Dec 31, 20133.07M1.95M
174.35%
Dec 31, 20121.12M357.08K
46.92%
Dec 31, 2011761.04K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.12B
Agiliti 1.16B
Avanos Medical 749.90M
Collegium Pharmaceutical 546.64M
MiMedx Group 309.02M
Innoviva 290.43M
Paragon 28 207.34M
Quanterix 116.64M
Revenue Rankings

ADMA News

More News